For this, we exploited knock-in mice expressing the pathogenic LRRK2-R1441C mutation found in PD patients that has been previously shown to increase LRRK2 kinase activity in both murine cells and in humans (Alessi and Sammler, 2018). The gene discussed is LRRK2; the disease is Parkinson disease.